SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-023366
Filing Date
2021-05-04
Accepted
2021-05-04 16:24:55
Documents
69
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arvn-10q_20210331.htm   iXBRL 10-Q 1355234
2 EX-31.1 arvn-ex311_7.htm EX-31.1 21046
3 EX-31.2 arvn-ex312_8.htm EX-31.2 21045
4 EX-32.1 arvn-ex321_9.htm EX-32.1 9484
5 EX-32.2 arvn-ex322_6.htm EX-32.2 9406
  Complete submission text file 0001564590-21-023366.txt   5807679

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arvn-20210331.xsd EX-101.SCH 48491
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arvn-20210331_cal.xml EX-101.CAL 42755
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arvn-20210331_def.xml EX-101.DEF 169112
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arvn-20210331_lab.xml EX-101.LAB 380999
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arvn-20210331_pre.xml EX-101.PRE 294192
11 EXTRACTED XBRL INSTANCE DOCUMENT arvn-10q_20210331_htm.xml XML 963611
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38672 | Film No.: 21888870
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences